Navigation Links
Weill Cornell team discovers how brain's own tPA helps regulate blood flow to neurons
Date:1/17/2008

NEW YORK (Jan. 17, 2008) -- The human brain contains its own store of a powerful enzyme (and stroke drug) called tissue plasminogen activator (tPA), which appears to be a key regulator of blood flow to brain cells, a team at the Weill Cornell Medical College in New York City reports.

"We found that this natural tPA boosts blood flow to brain cells via its influence on nitric oxide synthase, which is essential to the production of nitric oxide (NO). NO is a well-known vasodilator -- a drug or chemical that widens blood vessels -- so, more NO means better blood flow to neurons as they become more active," explains study senior author Dr. Costantino Iadecola, the George C. Cotzias Distinguished Professor of Neurology and Neuroscience at Weill Cornell Medical College, and chief of the Division of Neurobiology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

The findings have just been published in this week's online issue of Proceedings of the National Academies of Science.

Besides elucidating the role of naturally produced tPA in neuronal blood flow, the new findings could have implications for the study of stroke and Alzheimer's disease. Both conditions are associated with marked declines in natural brain levels of tPA.

TPA has become a star of sorts in cardiovascular research over the past two decades, ever since scientists discovered its remarkable ability to break up clots.

"Essentially, tPA, a powerful protease enzyme, cleaves a protein called plasminogen into plasmin, an enzyme that quickly 'eats up' clots," notes study lead author Dr. Laibaik Park, instructor in neuroscience at Weill Cornell. For that reason, doctors often administer a shot of tPA to stroke patients within minutes or hours of an attack.

But other research had also detected tPA occurring naturally in the human brain, with levels of the enzyme rising as brain cell activity increased.

"What really piqued our interest
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. $13 million federal grant for research into vascular disease awarded to Weill Cornell
2. 2 federal public health grants awarded to Weill Cornell Medical College
3. Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports
4. Cornell patents a pink lily look-alike that blooms all summer long
5. Cornell researchers prove how plants transport sugars
6. Cornell researcher seeks clues to how tuberculosis infects cells
7. Wiggle room: Cornell researcher borrows idea from sperm to provide energy for nanoscale robots
8. First symposium of UN University-Cornell Africa Series to be held at UN
9. Cornell will host the Northeast Biofuel Summit, Nov. 11-13
10. CU-Boulder team discovers first ancient manioc fields in Americas
11. deCODE discovers cause of major subtype of glaucoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...erhead sharks are some of the Ocean,s most distinc...they have this strange head shape, says Michelle ...ble reason is the shark,s vision. ,Perhaps their v...shape, says McComb, giving the sharks excellent s...ng to McComb, there were two schools of thought on...
(Date:11/26/2009)...ed for their impressive antlers, red deer have bee...ut a deer,s antlers are much more than decorative.... when duelling. John Currey, from The University o...roperties of bone for over half a century and has ...antler through a long-standing collaboration with ...
(Date:11/26/2009)...ogists have at last worked out a way of using reco...of bird populations. This is the first time sound ...lated into accurate estimates of bird species, pop...he British Ecological Society,s Journal of Applie...ld lead to a major advance in our ability to monit...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Tough yet stiff deer antler is materials scientist's dream 2Ecologists sound out new solution for monitoring cryptic species 2New Anesthesia May Be Safer for Critically Ill 52600 1New Anesthesia May Be Safer for Critically Ill 52600 2International conference on CO2 sequestration processes 9337 1Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 1Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 2Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 3
...cher known for her honey bee line "New World Carni...ounterparts to enhance their positive characterist...nd very productive, and hopefully will confer incr...vis bee breeder-geneticist Susan Cobey. , The Car...ubspecies of the Western honey bee. The subspecies...
...astic limbs and metal rods to complex virtual huma... dummies of yesteryear are evolving and researcher... among those bringing them to life. , This new g... humans with precision and detail not known in res...tailed representation of the bones and soft tissue...
...oulder study showing that American toads who pal a... parasitic infections known to cause limb malforma...biodiversity on emerging wildlife diseases. , The...re raised in tanks with the parasitic trematodes -... regions and disrupt normal leg development -- 40 ...
Other Biology News:Building a better bee 2Wake Forest plays integral role in effort to revolutionize vehicle safety 2Wake Forest plays integral role in effort to revolutionize vehicle safety 3New CU-Boulder study shows diversity decreases chances of parasitic disease 2New CU-Boulder study shows diversity decreases chances of parasitic disease 3
(Date:11/27/2009)...URHAM, N.C., Nov. 27 Cromoz Inc., ...ater-soluble carbon nanotube-based cancer drug del...e carbon nanotubes, which have functional groups o...r drugs, was developed in partnership with the Ind...on nanotubes serves as a drug delivery vehicle wit...
(Date:11/25/2009)...URHAM, N.C., Nov. 25 Research Tria...rgy-efficient, single-treatment water purification...es to Andhra Pradesh, Minister of Rural Water Supp...derabad, India today. Initial tests, performed at ...rmed that the majority of the drinking water avail...
(Date:11/25/2009)..., ON, Nov. 25 /PRNewswire/ - Cytochroma today anno...oard of Directors. Dr. Moldt will replace Mr. Ulri...any,s Board. The number of Board members remains u...d to welcome Peter Moldt to the board and look for...e as Cytochroma continues to make progress in beco...
(Date:11/24/2009)...available in German . , Whether it,s CD pac...ags (Radio Frequency Identification) are increasin...e it possible to label objects or goods and identi...opriate scanner can read and process the data cont... goods under production conditions of up to 100 de...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2
...entia Biotech Inc., a privately held,biopharmaceut...dy,therapeutics focused on cancer, announced today...urther advance and realize value from its,pipeline... platform and its,antibody manufacturing capabilit... opportunities including, but not limited to, the ...
...HAI Market; Market Expenditures for MRSA ...2, SUNNYVALE, Calif., Jan. 29 Cepheid (Nasdaq:,C... a medical device,license for the Xpert(TM) MRSA t...nt Staphylococcus aureus (MRSA) on nasal swabs and...are available in approximately 70 minutes,thereby ...
...sia Ltd, a specialty,biopharmaceutical company foc...ced today that it has successfully raised GBP11 mi...round funding. The investment,syndicate includes n...as,well as existing investors, including Imperial ...this financing is a testament to the potential of,...
Other Biology Technology:Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 3Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 4Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 5Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 6Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 2Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 3Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 4Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding 2
Mouse Anti-SERCA 1 ATPase Monoclonal Antibody, Unconjugated, Clone IIH11 from Novus Biologicals
Vitality pIRES-hrGFP-1 Vector from Stratagene
Rabbit Serum from BioVision
...The Zero Background Cloning Kit includes the pZErO...E. coli. The pZErO-1 vector utilizes positive sele... of the Zeocin resistance gene reduces the overall...tion efficiencies. The kit contains all of the rea...
Biology Products: